AI-assisted, source-referenced information. Independent clinical review is pending. Our standards.
The short answer

Foundayo is a systemic GLP-1 medicine despite being a tablet with flexible meal timing. Record symptoms alongside dose changes and other prescriptions, and distinguish routine advice from urgent assessment.

Describe how symptoms affect daily life

The UK information lists gastrointestinal effects including nausea, vomiting, diarrhoea, constipation and reflux. Symptoms may be more noticeable during escalation. Report what happens, how long it lasts and whether it prevents normal eating or drinking. Flexible meal instructions do not remove the need for a tolerability review.

Avoid classifying a symptom as acceptable just because it appears on the leaflet. Frequency categories describe groups, not the seriousness of a particular episode. A symptom affecting work, sleep or adequate intake is useful information for the prescriber even if you are still losing weight.

Sources: Eli Lilly / electronic medicines compendium: Foundayo: patient information leaflet; Eli Lilly / electronic medicines compendium: Foundayo: UK Summary of Product Characteristics, revised 3 November 2026

A new medicine can change the assessment

Foundayo has clinically relevant interactions, so mention prescriptions started or stopped around the time symptoms changed. Include antibiotics, antifungals, cholesterol medicines, anticonvulsants and herbal products. This is not a complete interaction list; the pharmacist needs the exact products and strengths to assess the combination.

Do not independently stop another essential medicine or assume that spacing tablets a few hours apart resolves an interaction. Ask the prescriber to explain any dose adjustment, monitoring or alternative treatment. Keep the advice available when the temporary medicine ends, since that may require another check.

Sources: Eli Lilly / electronic medicines compendium: Foundayo: UK Summary of Product Characteristics, revised 3 November 2026; Eli Lilly / electronic medicines compendium: Foundayo: patient information leaflet

Dizziness has more than one possible explanation

Tell the clinician about dizziness on standing, faintness, vomiting or diarrhoea, and whether you take blood-pressure medicines. The leaflet highlights low blood pressure as a consideration. If you use insulin or a sulfonylurea, hypoglycaemia is another issue that needs the diabetes plan to be followed.

Record relevant glucose or blood-pressure readings only if you already have instructions for monitoring, and bring symptoms as well as numbers. Do not alter treatment based on a single reading without appropriate advice. Seek prompt help for significant dehydration, collapse or severe symptoms, and avoid driving when impaired.

Sources: Eli Lilly / electronic medicines compendium: Foundayo: patient information leaflet; NHS: Dehydration: symptoms and when to get help; NHS: Low blood sugar: hypoglycaemia

Know the symptoms that should not wait

Severe persistent abdominal pain, particularly with pain in the back or vomiting, requires immediate medical assessment. Foundayo's leaflet identifies pancreatitis as a serious risk. Upper abdominal pain with fever or jaundice may also indicate a gallbladder problem and needs urgent assessment.

Call 999 for breathing difficulty, swelling of the mouth or throat, or collapse suggesting a serious allergic reaction. Give clinicians the brand, strength and last dose date, including privately prescribed treatment. An online message awaiting a response is not an adequate plan for a medical emergency.

Sources: Eli Lilly / electronic medicines compendium: Foundayo: patient information leaflet; NHS: Gallstones: symptoms and urgent help; NHS: Anaphylaxis: emergency symptoms and action

Reassess before the next dose increase

The escalation schedule allows assessment of response and tolerability. Ask how persistent symptoms affect the next planned step and whether another review or investigation is needed. If symptoms arose after starting a new prescription, make sure the clinician responsible for that medicine also receives relevant information.

After the discussion, confirm the next dose and contact threshold in writing. Report suspected adverse effects to Yellow Card where appropriate, but do not wait for a reporting response before obtaining care. The outcome should be a practical clinical plan, not simply an entry on a side-effect list.

Sources: Eli Lilly / electronic medicines compendium: Foundayo: UK Summary of Product Characteristics, revised 3 November 2026; MHRA: GLP-1 medicines for weight loss and diabetes: what you need to know

Questions, answered.

Does taking Foundayo with food prevent side effects?

Its instructions permit use with or without food, but that does not guarantee symptom prevention. Discuss persistent symptoms with the prescriber.

Sources: Eli Lilly / electronic medicines compendium: Foundayo: patient information leaflet

Can I solve an interaction by taking medicines at different times?

Do not assume so. Ask a pharmacist to assess the exact interaction and follow the resulting prescription plan.

Sources: Eli Lilly / electronic medicines compendium: Foundayo: UK Summary of Product Characteristics, revised 3 November 2026

Sources & further reading

Original sources for this guide. Source checks are not independent clinical review.

  1. Foundayo: patient information leafletEli Lilly / electronic medicines compendium · Accessed 19 November 2026
  2. Foundayo: UK Summary of Product Characteristics, revised 3 November 2026Eli Lilly / electronic medicines compendium · Accessed 19 November 2026
  3. Dehydration: symptoms and when to get helpNHS · Accessed 19 November 2026
  4. Low blood sugar: hypoglycaemiaNHS · Accessed 19 November 2026
  5. Gallstones: symptoms and urgent helpNHS · Accessed 19 November 2026
  6. Anaphylaxis: emergency symptoms and actionNHS · Accessed 19 November 2026
  7. GLP-1 medicines for weight loss and diabetes: what you need to knowMHRA · Accessed 19 November 2026